Tinea capitis.
Smith
M L
ML
Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D006118:Griseofulvin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007654:Ketoconazole / Q000008:administration & dosage / Q000009:adverse effects; D014006:Tinea Capitis / Q000175:diagnosis / Q000188:drug therapy*
D000935:Antifungal Agents; D006118:Griseofulvin; D007654:Ketoconazole